癌症化疗最新进展：贝伐单抗、依托泊苷和顺铂方案治疗难治性脑转移瘤
Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases.
作者信息
Mayer Seth A, Solimando Dominic A, Waddell J Aubrey
机构信息
Walter Reed National Military Medical Center, Bethesda, MD, USA.
Oncology Pharmacy Services, Inc, Arlington, VA, USA.
出版信息
Hosp Pharm. 2017 Jun;52(6):394-399. doi: 10.1177/0018578717717622. Epub 2017 Aug 20.
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc, 4201 Wilson Blvd #110-545, Arlington, VA 22203, email: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, email: waddfour@charter.net. Bevacizumab, etoposide, and cisplatin (BEEP) The regimen is named for the medications it contains: vacizumab, toposide, and cislatin.
癌症化疗的复杂性要求药剂师熟悉所使用的复杂治疗方案和高毒性药物。本专栏回顾了与抗肿瘤治疗的制备、调配和给药相关的各种问题，以及用于治疗恶性疾病的市售和研究性药物。有关主题的问题或建议应发送至：小多米尼克·A·索利曼多，肿瘤药学服务公司总裁，弗吉尼亚州阿灵顿市威尔逊大道4201号#110 - 545，邮编22203，电子邮箱：OncRxSvc@comcast.net；或J·奥布里·沃德尔，田纳西大学药学院教授；布朗特纪念医院药剂科肿瘤药师，田纳西州玛丽维尔市东拉马尔·亚历山大公园大道907号，邮编37804，电子邮箱：waddfour@charter.net。贝伐单抗、依托泊苷和顺铂（BEEP）该方案以其所含药物命名：贝伐单抗、依托泊苷和顺铂。
Zotero 插件